Warwick-Aston Engineering Biology Project Receives £1.8m Grant for Membrane Protein Research

(IN BRIEF) The University of Warwick and Aston University have secured a £1.8 million grant to advance research in engineering microbial cell factories for the production of membrane proteins, crucial molecules in drug discovery and sustainable manufacturing. Funded by the UK Research and Innovation Technology Missions Fund, the project aims to overcome challenges in protein production by identifying cellular bottlenecks and optimizing the membrane environment. Led by Dr. Alexander Darlington from Warwick and Dr. Doug Browning from Aston, the interdisciplinary team will employ cutting-edge computational and molecular biology tools to enhance the efficiency of drug screening and develop sustainable chemical production processes. This initiative represents a significant step towards revolutionizing biomedical research and advancing the field of membrane protein engineering.

(PRESS RELEASE) COVENTRY, 10-Feb-2023 — /EuropaWire/ — A team of academics from The University of Warwick and Aston University has secured a £1.8m grant to engineer microbial cell factories to produce membrane proteins which will support future drug screening and sustainable chemical production.

Membrane proteins are crucial molecules on the surface of cells with numerous biological functions, such as sensing hormones or cell communication. The top ten selling medicines worldwide and multiple vaccines, including those for COVID-19, Hepatitis B and whooping cough, target membrane proteins.

Manufacture and purification of membrane proteins is also frequently used in pharmacology to identify new drug molecules which may inhibit or activate protein function.

However, engineering the production of high levels of functional membrane proteins is challenging due to biological and technological roadblocks because the complex processes of membrane production place large amounts of stress on cells. This limits the efficiency of drug screening and reduces the chances of discovering new drugs.

Thanks to funding from the UK Research and Innovation (UKRI) Technology Missions Fund, the research team will focus their efforts on two of these challenges: the identification of cellular production bottlenecks and cellular stresses; and the membrane environment that surrounds the proteins.

By combining state-of-the-art computational whole cell models and molecular dynamics simulations with cutting edge molecular biology and biochemistry tools, the team will engineer microbial cell factories which can self-regulate their protein production in response to stress and have the optimal membrane environment to support protein function. Together, these new technologies will increase yields of high-quality functional proteins, simplifying and shortening the time required to produce key biomedical proteins for drug screening.

Some membrane proteins are useful as catalysts for the production of sustainable chemicals. For example, some membrane enzymes can be used to fix carbon, reacting carbon dioxide from the air and enable cells to turned them into useful chemicals that can be used as feedstocks in biomanufacturing processes, while others can degrade plastics. The team look forward to exploring these applications with academic and industrial collaborators.

Project Lead Dr Alexander Darlington, Royal Academy of Engineering Research Fellow and Assistant Professor, School of Engineering, at the University of Warwick, said: “We use feedback control in our everyday lives – think of a thermostat which only calls for heat when the temperature drops below a certain level or a car’s cruise control which mains constant speed irrespective of hills. Incorporating these engineering concepts into cellular manufacturing platforms will enable cells to balance their own health against production of our desired proteins and enable us to achieve higher yields of important drug targets for future research.

“I am delighted that our project has been selected for funding and am looking forward to working with the wider research team across Warwick, Aston and our industrial partners. We’ll be organising a series of seminars and workshops to discuss the wider challenges of membrane protein engineering and we are excited about the future collaborative opportunities we hope these bring.”

Dr Doug Browning, Lecturer in Biosciences at Aston University, said: “We are absolutely thrilled to receive an Engineering Biology Mission Award, with our colleagues at Warwick. This funding, in conjunction with our industrial partners, will enable us to design and construct new expression systems that will produce high-value membrane therapeutics, which can be used in the fight against many important medical diseases. This award builds on the recent establishment of the Aston Institute for Membrane Excellence (AIME), with a £10m grant from Research England, and firmly places Aston at the forefront of membrane biology.”

Professor Phillip Stansfeld, School of Life Sciences, University of Warwick added: “Membrane proteins are integral to both life and the development of novel therapeutics; however, these proteins remain difficult to characterise structurally. With the recent computational revolution in protein-structure prediction and design approaches, it is timely to study the dynamics of computationally-optimised membrane proteins and develop approaches to rationally escalate their structural determination.”

About UK Research and Innovation

UK Research and Innovation (UKRI) is the largest public funder of research and innovation in the UK, investing £8 billion annually spanning all disciplines and all sectors. We are nine councils, drawing on our unique breadth and depth of expertise to work with government and other stakeholders to enrich lives, by increasing our understanding of ourselves and the world around us, supporting innovative businesses and public services, and creating high-quality jobs throughout the UK.

About UKRI Technology Missions

The new UKRI Technology Missions funding is designed to exploit the UK’s global leadership in transformative technologies to help solve specific problems, whilst also helping cement that leading position. Overall, UKRI is investing £250 million in Technology Missions to enable new and existing capabilities and capacity in artificial intelligence, quantum technologies and engineering biology in the years 2023-2025 and beyond. With a further £70 million announced to support future telecommunications.

About the National Vision for Engineering Biology

The National Vision for Engineering Biology published in December 2023 defines the UK Government’s collective ambition for engineering biology and sets the direction in which government investment, policy and regulatory reform will deliver through the strands of the Science and Technology Framework.

About Aston University

For over a century, Aston University’s enduring purpose has been to make our world a better place through education, research and innovation, by enabling our students to succeed in work and life, and by supporting our communities to thrive economically, socially and culturally.

Aston University’s history has been intertwined with the history of Birmingham, a remarkable city that once was the heartland of the Industrial Revolution and the manufacturing powerhouse of the world.

Born out of the First Industrial Revolution, Aston University has a proud and distinct heritage dating back to our formation as the School of Metallurgy in 1875, the first UK College of Technology in 1951, gaining university status by Royal Charter in 1966, and becoming the Guardian University of the Year in 2020.

Building on our outstanding past, we are now defining our place and role in the Fourth Industrial Revolution (and beyond) within a rapidly changing world.

For media inquiries in relation to this release, contact Helen Tunnicliffe, Press and Communications Manager, on (+44) 7827 090240 or email: h.tunnicliffe@aston.ac.uk.

Media Contact:

Annie Slinn
07876876934
Communications Officer | Press & Media Relations | University of Warwick
Email: annie.slinn@warwick.ac.uk

SOURCE: University of Warwick